Biomarker Discovery & Validation

Lunit adds AstraZeneca for NSCLC biomarker screening AI
By LabPulse.com staff writers
Companies to integrate Scope Genotype Predictor into pathology workflows to screen for actionable mutations in non-small cell lung cancer research.
November 18, 2024
Nsclc Slides
Sunbird Bio shares new data on blood-based Parkinson's diagnostic
By LabPulse.com staff writers
Biotech firm Sunbird Bio announced new data from a study demonstrating that Sunbird's technology could provide blood-based diagnosis of Parkinson's disease and other neurodegenerative diseases with a high level of accuracy.
November 1, 2024
Parkinsons Lewy Bodies Social
Alzheimer's panel validated in University of Pittsburgh study
By LabPulse.com staff writers
A team at the University of Pittsburgh has validated a new blood test panel that can simultaneously measure over 100 Alzheimer's disease biomarkers.
November 4, 2024
Alzheimers Tau Tangles Social
Molecular You partners with Calif. reference lab for biomarker testing
By LabPulse.com staff writers
Multiomic test developer Molecular You and reference laboratory HealthQuest Esoterics have partnered to expand predictive biomarker testing to healthcare clinics across the U.S.
October 21, 2024
Blood Test Samples Lab (1)
Owlstone, FDA's OSEL partner to develop VOC ID methods
By LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Rapid diagnostic test developed for ALS
By LabPulse.com staff writers
A blood diagnostic test for amyotrophic lateral sclerosis (ALS) has been developed that can rapidly distinguish ALS from conditions that mimic ALS in its early stages with a high level of specificity and sensitivity.
September 13, 2024
Nerve Neuron Axon Social
Analysis: Biomarker testing and targeted therapy underutilized in U.S. NSCLC patients
By LabPulse.com staff writers
Biomarker testing and targeted therapy is significantly underused for patients with non-small cell lung cancer (NSCLC) in the U.S., according to an analysis of point-of-care real-world data conducted by Amplity Health.
June 10, 2024
Artificial Intelligence Lung Color Social
FDA clears another blood-based TBI POC test
By LabPulse.com staff writers
Abbott furthers its point-of-care (POC) assay for measuring traumatic brain injury biomarkers from whole blood.
April 1, 2024
Brain Abstract Social
Researchers map protein biomarkers in sepsis fight
By Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Sepsis Bacteria Social
Two new directions in Parkinson’s testing
By Liz Carey
Two recent Parkinson’s announcements suggest a new biomarker test panel coming, as well as cell culture systems for studying Parkinson’s in the laboratory.
December 11, 2023
Parkinsons Definition Social
Study: Blood test improves bipolar disorder diagnosis through biomarkers
By Matt Limb
Diagnosis of bipolar disorder could be improved using a simple blood test to identify biomarkers associated with the condition, say researchers.
November 2, 2023
Computer Brain Hemisphere Social
Researchers develop nanopore sequencing method for mapping disease biomarkers
By Matt Limb
A nanopore sequencing method that can map dozens of biomarkers at the same time has the potential to transform testing for heart disease and other conditions, say researchers.
October 11, 2023
Genome Sequence Barcode Social
Page 1 of 5
Next Page